The effect of intravenous or subcutaneous administration of meglumine antimonate (glucantime®) in dogs with leishmaniasis. A randomized clinical trial

Veterinary Quarterly

Volumn 19, Issue 1, 1997, Pages 10-13

  Slappendel, R J ^a   Teske, E ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Glucantime® ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG EFFICACY; KIDNEY FAILURE; LEISHMANIASIS; NONHUMAN; REMISSION; SURVIVAL; THROMBOPHLEBITIS;

ANIMALS; ANTIMONY; ANTIPROTOZOAL AGENTS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LEISHMANIASIS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031427424     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.1997.9694729     Document Type: Article

References (11)

1. Berenger A. Proposition d’une modalité particulière de traitement de la leishmaniose canine. Guérison possible. Pratique Medicate et Chirurgicale de l’Animal de Compagnie 1988; 23: 111–9.
2. Bergeaud P. L’apport de la corticothérapie dans le traitement de certaines formes de leishmaniose canine: Résultats sur une série de 43 cas. Pratique Medicate et Chirurgicale de l’Animal de Compagnie 1988; 23: 120–7.
3. Euzeby J. Leishmaniose generale du chien. In: Euzeby J, Protozoologie medicate comparée, vol 1, Collection Fondation Marcel Merieux, Lyon (F), 1986: 280–313.
4. Ferrer L. Leishmaniasis. In: Kirk-Bonagura (Eds): Current veterinary therapy XI, Saunders, Philadelphia, 1992: 266–70.
5. Gradoni L, Maroli M, Grammicia M, and Mancianti F. Leishmania infant=infection rates in phlebotomus pernisiosus fed on paturally infected dogs under antimonial treatment. Med Vet Ent 1987; 1: 339–42.
6. Harith AE, Slappendel RJ, Reiter I, Knapen F van, Korte P de, Huigen E, and Kolk AHJ. Application of a direct agglutination test for detection of specific anti-leishmania antibodies in the canine reservoir. J clin Microbiol 1989; 27: 2252–7.
7. Kammermann-Liischer B. Leishmaniose beim Hund. Schweiz Arch Tierheilk 1980; 122: 585–603.
8. Lanotte G, Rioux JA, Perieres J, and Vollhardt Y. Ecologic des Leishmanioses dans le sud de la France. 10. Les formes evolutives de la leishmaniose viscerale canine. Ann Parasitol Hum Comp 1979; 54: 277.
9. Longstaffe JA, and Guy MW: Canine leishmaniasis-United Kingdom update. J Small Anim Pract 1986; 27: 663–71.
10. Schawalder P. Leishmaniose bei Hund und Katze. Kleintier Praxis 1977; 22: 237–46.
11. Slappendel RJ. Canine leishmaniasis. A review based on 95 cases in the Netherlands. Vet Quart 1988; 10: 1–16.